Content

AI breakthrough in diagnosing heart disease

Heartflow has become the first FDA-approved AI algorithm for diagnosing cardiac diseases, marking a major milestone in healthcare innovation.

This is premium content

You are not logged in, Sign in or register to request access.
Please note: If you had prior access to this content you may need to sign in again.

Asset Owners

If you are an institutional investor you are eligable for free access to all premium content.

Asset Managers

Asset managers with enhanced profiles are eligable for full access.

Please sign-in using your work email address or:

UBS Asset Management

AI breakthrough in diagnosing heart disease

This is premium content

Asset Owners

Asset Managers

UBS Asset Management

Related categories